Literature DB >> 10329465

Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues.

K W Adolph1.   

Abstract

The levels of thrombospondin 2 (TSP2) and thrombospondin 3 (TSP3) mRNAs in a variety of human tissues were determined by analysis of multiple-tissue mRNA dot blots. For TSP2 mRNA, aorta and fetal heart had the greatest relative abundance. High levels were also detected for muscle, fetal, endocrine, immune, and nerve tissues. The pattern of expression of TSP3 mRNA was very different: kidney, pituitary gland, trachea, uterus, and fetal kidney had the greatest abundance. In general, TSP3 mRNA was expressed at high levels in endocrine, muscle, and fetal tissues. In addition to the tissue-specific differences, a more even distribution of TSP3 mRNA among tissues was observed. The high relative abundance of the two mRNAs in a variety of tissues and the tissue-specific differences in expression could be significant for understanding the diverse roles implicated for TSP2 and TSP3. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329465     DOI: 10.1006/bbrc.1999.0710

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Thrombospondins in the transition from myocardial infarction to heart failure.

Authors:  Jonathan A Kirk; Oscar H Cingolani
Journal:  J Mol Cell Cardiol       Date:  2015-12-10       Impact factor: 5.000

2.  Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral head.

Authors:  Kurt D Hankenson; Sheriar G Hormuzdi; Jeffrey A Meganck; Paul Bornstein
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 3.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 4.  The extracellular matrix of hematopoietic stem cell niches.

Authors:  Cornelia Lee-Thedieck; Peter Schertl; Gerd Klein
Journal:  Adv Drug Deliv Rev       Date:  2021-11-25       Impact factor: 15.470

5.  Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF.

Authors:  Hidehisa Horiguchi; Long Jin; Katharina H Ruebel; Bernd W Scheithauer; Ricardo V Lloyd
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

Review 6.  Thrombospondins: old players, new games.

Authors:  Olga Stenina-Adognravi
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

7.  Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts.

Authors:  Andrea Sadlonova; Damon B Bowe; Zdenek Novak; Shibani Mukherjee; Virginia E Duncan; Grier P Page; Andra R Frost
Journal:  Cancer Microenviron       Date:  2009-03-18

Review 8.  Thrombospondins: A Role in Cardiovascular Disease.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2017-07-17       Impact factor: 5.923

9.  Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.

Authors:  Tobias G Schips; Davy Vanhoutte; Alexander Vo; Robert N Correll; Matthew J Brody; Hadi Khalil; Jason Karch; Andoria Tjondrokoesoemo; Michelle A Sargent; Marjorie Maillet; Robert S Ross; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2019-01-08       Impact factor: 14.919

Review 10.  The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis.

Authors:  Michael Chute; Preetinder Aujla; Sayantan Jana; Zamaneh Kassiri
Journal:  J Cardiovasc Dev Dis       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.